CARE assigns rating to Mangalam Drugs & Organics’ bank facilities

19 Jun 2015 Evaluate

Credit rating agency, CARE has assigned ‘BB+’ rating to Mangalam Drugs & Organics’ Long-term bank facilities worth Rs 14 crore. The rating agency has also assigned ‘A4+’ rating to company’s Short-term Bank Facilities worth Rs 6 crore.

The ratings assigned to the bank facilities of Mangalam Drugs and Organics (MDOL) are constrained by its relatively small scale of operations in the Active Pharmaceutical Ingredients (APIs)/ Bulk Drugs Industry along with limited product offerings, client concentration risk and working capital-intensive nature of operations. The ratings also factor in MDOL’s low profitability margins and its susceptibility to foreign exchange fluctuation, volatile raw material prices as well as prevailing intense competition in the API/Bulk drugs industry

Mangalam Drugs & Organics is engaged in manufacturing of Active Pharmaceutical Ingredients APIs, Intermediates at VAPI, Gujarat.

Mangalam Drugs&Org. Share Price

25.34 0.01 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×